Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Pleural mesothelioma: tackling a deadly cancer

February 11, 2019 By Law Offices of Thomas J. Lamb, P.A.

A new study from the University of Pittsburgh has highlighted six factors that are associated with improved survival in patients with mesothelioma; age under 45 years, female, epithelioid histological subtype, peritoneal mesothelioma, stage 1 cancer, and being treated with both surgery and chemotherapy. This knowledge, together with recent reports showing promising findings from the use of new targeted immunotherapy agents in malignant pleural mesothelioma, provides new hope for this rare and deadly cancer.

Mesothelioma is usually caused by exposure to asbestos, and predominantly affects the lining of the lungs—so-called pleural mesothelioma. Patients with pleural mesothelioma have a poor median survival from diagnosis of around 1 year. A report from the International Agency for Research on Cancer indicates that the disease burden is still substantial with 30,443 cases of malignant mesothelioma, and 25,576 deaths worldwide, according to GLOBOCAN 2018 statistics. Identification of patients with a good prognosis is key to appropriate management. The Pittsburgh researchers used the National Mesothelioma Virtual Bank, a US collection of de-identified biospecimens, to assess survival according to clinical factors. They assessed 888 patients diagnosed between 1990 and 2017 to identify the six factors associated with a better survival. Such analyses can provide guidance on those patients who might respond best to treatment as well as indicate stratification factors for future trials.

Surgery is a possible option for patients; however, it can be both challenging and associated with subsequent morbidity. Furthermore, not all patients are eligible for surgery, depending on their overall fitness and the type and site of the cancer. There is currently only one FDA-approved first-line treatment; a platinum-based doublet and pemetrexed….

[Article continues at original source]

 Mesothelioma, Asbestos, and Legal Compensation: Basic Facts

Asbestos-Mesothelioma Case Evaluation Form
Free.  Confidential.  No Obligation.

Filed Under: Asbestos, Mesothelioma Tagged With: malignant pleural mesothelioma (MPM), mesothelioma, mesothelioma treatments

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.